Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2229690 | 0.88 | MEN1 (0.66) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| Diethanolamine SCHEMBL16212 | 0.87 | AKR1C3 (0.47) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL6388241 | 0.77 | MEN1 (0.65) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL8408159 | 0.77 | MEN1 (0.65) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL11683148 | 0.77 | MEN1 (0.46) | MEN1KMT2AALDH1A1AKR1C3HTT | |
| SCHEMBL27655716 | 0.77 | MEN1 (0.74) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL528920 | 0.76 | MEN1 (0.49) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL8330995 | 0.75 | MEN1 (0.62) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL14332131 | 0.75 | CA12 (0.54) | MEN1KMT2AALDH1A1NR1H4KDM4E | |
| SCHEMBL5504208 | 0.75 | MEN1 (0.62) | MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2474302-B1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | ADEKA CORP (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-9498653-B2 | Sunscreen cosmetic composition containing ultraviolet absorber | ADEKA CORPORATION (JP) | 2016-11-22 | — | — | US | disclosed |
| EP-2474302-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | Adeka Corporation (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120093747-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | ADEKA CORPORATION (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120093747-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | CYP8B1, TYR, ERCC5 | MEN1 1059/4885KMT2A 3556/4885SMN1; SMN2 4495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.